The TrkB receptor tyrosine kinase (RTK) is a high anity receptor for the neurotrophins brain derived neurotrophic factor (BDNF) and neurotrophin-4/5 (NT-4/5). Following exposure to BDNF or NT-4/5, TrkB is autophosphorylated on ®ve cytoplasmic tyrosines: Y484, Y670, Y674, Y675, and Y785. Based on crystallographic analyses for others RTKs, TrkB tyrosines Y670, Y674, and Y675 are expected to lie within a putative kinase activation loop. Phosphorylation of these activation loop tyrosines is postulated to be a conserved event required for complete RTK activation. Here, we have assessed the importance these activation loop tyrosines play in regulating TrkB autophosphorylation, cytoplasmic signal transduction, and cell proliferation. We show that while tyrosine 670 is dispensable for BDNF-inducible TrkB autophosphorylation and the activation of certain signal transduction events, it is required for complete TrkBmediated cellular proliferation. Combinatorial mutagenesis of tyrosines 674 and 675 only moderately aects TrkB autophosphorylation, but signi®cantly impairs the BDNF-inducible stimulation of cytoplasmic signaling events and cellular proliferation. The combined mutation of all three activation loop tyrosines results in an inactive receptor, which is unable to autophosphorylate, stimulate signaling events, or induce mitogenesis. The data highlight the varying degrees of importance of the three activation loop tyrosines in TrkB mediated biological responses.
Introduction
The proper development and maintenance of the vertebrate nervous system requires the actions of the nerve growth factor (NGF) family of neurotrophic factors, which includes NGF, brain derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3), neurotrophin-4/5 (NT-4/5) and neurotrophin-6 (NT-6). These neurotrophins were originally viewed solely as target derived trophic factors, regulating naturally occurring neuronal cell death during development and providing neuronal maintenance in maturity (for review, see Purves, 1988) . However, more recent work has shown that neurotrophins also act during neurogenesis, neuronal dierentiation, path®nding and synaptic eciency (for reviews, see Davies, 1994; Snider, 1994) .
Neurotrophin action is mediated via high anity binding with the Trk family of transmembrane receptors (for review, see Kaplan and Stephens, 1994) . TrkA receptors bind NGF, TrkB receptors bind BDNF and NT-4/5 (and to a lesser extent and TrkC binds NT-3. TrkA, TrkB and TrkC are encoded by separate genes and are each synthesized in multiple isoforms as a result of alternative RNA splicing. In each case, there is at least one isoform that is a receptor tyrosine kinase (RTK) capable of mediating ligand-dependent signal transduction. In the case of TrkB and TrkC, there are also multiple isoforms lacking the intracellular tyrosine kinase domain (Barbacid, 1994) .
Based upon the many actions of the neurotrophins and their potential utility as therapeutic agents for neurodegenerative conditions (Hefti, 1994) , there has been substantial interest in the molecular basis of Trk receptor action. Most of this eort has focused upon the structure and function of receptor tyrosine kinase isoforms. In the case of the TrkB-RTK, herein designated as simply TrkB, ligand-induced activation occurs through a conserved mechanism used by most RTKs (Schlessinger and Ullrich, 1992) . Ligand binding to the TrkB extracellular region promotes receptor dimerization, which activates the intrinsic tyrosine kinase domain, leading to autophosphorylation on speci®c receptor tyrosines. In addition to activating the kinase domain, autophosphorylation serves to recruit various cytoplasmic molecules to the activated receptor complex. In many cases, these molecules contain src homology 2 (SH2) domains (Pawson, 1995) or phosphotyrosine binding (PTB) domains (Borg and Margolis, 1995) , both of which bind to receptor phosphotyrosine-containing sequences. The quantitative and qualitative nature of these interactions subsequently activate multiple downstream cytoplasmic signaling cascades leading to a cellular response.
TrkB can elicit dierent cellular responses depending on the cellular context in which it is expressed. For example, PC12 cells, which do not normally express TrkB, dierentiate to a neuronal phenotype in response to BDNF following exogenous TrkB expression . Alternatively, exogenous expression of TrkB in NIH3T3 ®broblasts, followed by BDNF stimulation, produces a potent mitogenic eect Klein et al., 1991) . Deciphering the signaling pathways used by TrkB to elicit these diering cellular responses is crucial to understanding the normal role of the Trks in dierentiation and proliferation of cells within the nervous system. Furthermore, de®ning the molecular events regulating TrkB-mediated mitogenesis may help in understanding the potential oncogenic roles of the Trk receptors (Martin-Zanca et al., 1986; Nakagaware et al., 1994) .
To date, ®ve BDNF-inducible autophosphorylation sites have been identi®ed in the 368 amino acid intracellular region of TrkB (Guiton et al., 1994; Middlemas et al., 1994) . Tyrosine 484 (Y484) lies within the juxtamembrane region of TrkB. Based on its neighboring N-terminal amino acid sequence (NPQY), Y484 is predicted to be the binding site for the PTB domain of the SHC adapter protein. Indeed, the corresponding phosphorylated tyrosine (pY490) in TrkA is responsible for the NGF-inducible association of TrkA with SHC (Obermeier et al., 1993b; Stephens et al., 1994; Dikic et al., 1995) . Tyrosine 785 is in the extreme C-terminal region of TrkB. Based on mutational analysis of the corresponding TrkA tyrosine (also pY785), this phosphotyrosine is likely to be the binding site for the SH2-containing enzyme PLCg (Obermeier et al., 1993a; Loeb et al., 1994) . This interaction is believed to induce tyrosine phosphorylation of PLC-g as well, presumably via TrkB kinase activity (Middlemas et al., 1994) .
The remaining three tyrosine autophosphorylation sites, Y670, Y674 and Y675, lie within the TrkB catalytic domain (Figure 1a ). Based on comparison with the recent crystal structure determinations for the insulin receptor (Hubbard et al., 1994) and FGF receptor kinase domains (Mohammadi et al., 1996b) , TrkB residues Y670, Y674, and Y675 appear to lie within a structurally¯exible`activation loop'. Autophosphorylation of tyrosines within this region is postulated to induce conformational changes within the kinase domain, allowing the active site greater accessibility to substrates. Although it has not been demonstrated, it is possible that SH2 and/or PTB domain-containing proteins interact with one or more of the activation loop phosphotyrosines.
To address the functional importance of the three TrkB activation loop phosphorylation sites, we have assessed the ability of receptors containing various tyrosine to phenylalanine substitutions to stimulate signaling events in TrkB expressing NIH3T3 cells. In concurrence with other reports (Guiton et al., 1994; Segal et al., 1996; Cunningham et al., 1997) , we show that receptors containing the YY674/675FF double substitution and the Y670F single substitution are capable of BDNF-inducible receptor tyrosine autophosphorylation. Extending these ®ndings, we show that TrkB YY674/675FF is greatly impaired in its ability to stimulate the phosphorylation of SHC and PLCg, activate ERK1 and ERK2, induce c-fos protein synthesis, and stimulate NIH3T3 mitogenesis. The Y670F mutation, however, only partially aects the ability of the receptor to induce the tested signaling responses. Furthermore, receptors containing the Y670F mutation are capable of stimulating NIH3T3 proliferation, albeit to a lesser extent than wild type TrkB. Mutation of all three activation loop tyrosines, TrkB YYY670/674/675FFF, impairs both receptor tyrosine autophosphorylation and the activation of all tested downstream signaling events. These data suggest that while the phosphorylation of all three TrkB tyrosines within the activation loop are required for full signaling capabilities, individual tyrosines are partially dispensable for kinase activation and downstream signal transduction.
Results

Expression of wild type and mutant TrkB proteins
The ®ve known TrkB tyrosine phosphorylation sites are diagrammed in Figure 1a . Various tyrosine to phenylalanine site-directed substitutions were introduced into the rat TrkB cDNA, followed by sequencing to con®rm the presence of each mutation. The mutations include a Y670F single substitution, a YY674/675FF double substitution, and a YYY670/ 674/675FFF triple substitution. Additionally, we constructed a lysine to alanine substitution at amino acid 540, which has been shown to abolish all TrkB kinase activity (Guiton et al., 1994 (Barbacid, 1994) and/or proteolytic fragments of the intact TrkB protein.
BDNF-inducible tyrosine phosphorylation of TrkB and cellular proteins
To test the ability of the various TrkB proteins to autophosphorylate in response to BDNF, we ®rst performed a timecourse of BDNF treatment followed by TrkB immunoprecipitation and anti-phosphotyrosine Western analysis. As seen in Figure 2a , (Watts et al., 1992; Longati et al., 1994) . Wild type TrkB and the various mutants were immunoprecipitated and incubated with MBP in the presence of 32 P-g-ATP. Very little MBP phosphorylation was detected by immunoprecipitated TrkB K540A. However, immunoprecipitation of both wild type TrkB and TrkB Y670F markedly increased MBP phosphorylation. Unexpectedly, we found that both TrkB YY674/675FF and TrkB YYY670/674/675FFF showed MBP phosphorylation above background levels. Although the TrkB triple mutant displayed only a modest increase, immunoprecipitated TrkB YY674/675FF phosphorylated MBP at levels similar to that of the wild type and Y670F receptors. The enhanced activity of TrkB YY674/675FF correlated well with the ability of this receptor to autophosphorylate (Figure 2a) . Therefore, although TrkB YY674/675FF and YYY670/674/ 675FFF do not stimulate detectable in vivo increases in cellular protein tyrosine phosphorylation, the receptors appear to have some kinase activity using in vitro conditions. During these experiments we were unable to detect a signi®cant BDNF-inducible in vitro increase in TrkB kinase activity. This eect was not exclusive to MBP, since we observed a similar BDNFindependent activity towards the substrate enolase (data not shown). We believe this enhanced BDNFindependent activity is caused by the divalent nature of the pan-Trk antibody. The antibody recognition and subsequent immunoprecipitation may cause receptor aggregation, thus stimulating kinase activity in a ligand-independent manner. Indeed, a report by Longati et al. (1994) showed that c-Met immunoprecipitates possess HGF-independent kinase activity. Additionally, recombinantly expressed TrkA is capable of NGF-independent in vitro autophosphorylation when immunoprecipitated from Sf9 cells . Attempts using pan-Trk Fab fragments did not circumvent this problem (data not shown), likely due to a similar aggregation eect caused by the goat anti-rabbit-agarose used to precipitate the Fab fragments. Additionally, a recent report by Iwasaki et al. (1997) using the recombinantly expressed intracellular portion of TrkB suggests that the receptor is capable of an initial burst of cis, intramolecular autophosphorylation, which may account for at least some of the non-BDNF inducible TrkB kinase activity. The ability of wild type TrkB and the various mutants to stimulate the phosphorylation of cellular proteins was determined by a timecourse of BDNF treatment followed by anti-phosphotyrosine Western analysis of NP-40 soluble cell extracts. As shown in Figure 3a , application of BDNF to cells expressing wild type TrkB stimulated the phosphorylation of multiple cellular proteins (denoted by arrows). Although a similar quantitative pattern of protein phosphorylation was observed in cells expressing TrkB Y670F, a BDNF-inducible phosphoprotein of approximately 50 kDa transiently induced in the wild type TrkB lysates was absent in the Y670F lysates, indicating this mutation somehow qualitatively aects the tyrosine phosphorylation of cellular substrates. No signi®cant level of phosphotyrosine increase in response to BDNF was seen in the YY674/675FF expressing cells. Thus, while TrkB YY674/675FF receptors are capable of BDNF inducible autophosphorylation and possess in vitro kinase activity ( Figure  2b ), they are not capable of phosphorylating detectable levels of any cellular proteins. Finally, consistent with their inability to autophosphorylate, the K540A and YYY670/674/675FFF receptors did not elicit a BDNFinducible stimulation of cellular phosphotyrosine levels.
Eects of activation loop mutations on SHC and PLC tyrosine phosphorylation and TrkB association
SHC and PLCg are two cytoplasmic signaling molecules involved in TrkA and TrkB mediated signaling events (Obermeier et al., 1994; Middlemas et al., 1994) . We determined whether receptors harboring the various activation loop mutations were capable of stimulating PLCg and SHC phosphorylation (Figure 3b and d) . As shown, after 5 min of BDNF treatment, cells expressing wild type TrkB were capable of stimulating the phosphorylation of PLCg (Figure 3b) . TrkB Y670F cells, however, were not capable of inducing detectable PLCg phosphorylation, indicating that the presence of the Y670F substitution does partially impair TrkB mediated signaling events. Furthermore, only wild type TrkB could be co-immunoprecipitated with anti-PLCg antisera (Figure 3c ). Although basal levels of SHC phosphorylation varied in each cell line, only wild type TrkB and TrkB Y670F were capable of a BDNFinducible increase in the tyrosine phosphorylation of p46SHC and p52SHC (Figure 3d ). Consistent with these results, wild type TrkB and TrkB Y670F could be co-immunoprecipitated with anti-SHC antisera ( Figure  3e ). TrkB K540A, YY674/675FF, and YYY670/674/ 675FFF were all incapable of stimulating PLCg or SHC phosphorylation, coincident with the inability of the receptors to be co-immunoprecipitated with these signaling molecules. Together, these data further support the notion that substrate association with TrkB is required for subsequent tyrosine phosphorylation of the interacting protein.
BDNF-inducible activation of ERK1 and ERK2
A well characterized signaling cascade activated by many RTKs involves the dual speci®city extracellular regulated kinases 1 and 2 (ERK1 and ERK2) (for review see Marshall, 1994a) . RTK mediated stimulation of the p21ras GTPase leads to ERK activation via a series of phosphorylation events collectively termed the MAP kinase cascade. The ability of the MAP kinase cascade to elicit various cellular responses ranging from NIH3T3 transformation to PC12 dierentiation has been reported (Marshall, 1994b) , although the breadth of these ®ndings have recently been reassessed (Vallaincourt et al., 1995) . Nevertheless, the importance of ERK activation for TrkAmediated cellular responses has been well documented Obermeier et al., 1994) .
To test the ability of the various TrkB cell lines to stimulate the activation of ERK1 and ERK2, we employed a phospho-speci®c ERK1/2 polyclonal antiserum. This antibody recognizes only the phosphorylated and thus catalytically active form of ERK1/ 2. Cell lines expressing wild type TrkB and the various mutants were stimulated with BDNF, lysed, and the NP-40 soluble lysates were blotted and probed with the phospho-speci®c ERK1/2 antibody. The lysates were also probed with an ERK1/2 speci®c antibody to assure that equivalent amounts of ERKs were present in the various samples. As shown in Figure 4 , wild type and TrkB Y670F cells induced an activation of ERK1 and ERK2 within 5 min of BDNF treatment. Activation of ERK2 by wild type TrkB and TrkB Y670F was temporally indistinguishable and remained detectable for at least 60 min post-BDNF stimulation (data not shown). The K540A, YY674/675FF, and YYY670/674/675FFF cells did not stimulate ERK1/2 activation. Interestingly, the activation of ERK2 by both wild type and TrkB Y670F was signi®cantly more robust than ERK1 activation.
TrkB stimulation of c-fos protein synthesis
It is well established that many TrkB-mediated cellular responses are accompanied by an increase in c-fos protein levels within 30 ± 60 min following BDNF treatment Marsh et al., 1993) . Recent data suggest that induction of c-fos protein synthesis is dependent on ERK1 and ERK2 activation (Karin, 1994; Treisman, 1994) . To test the ability of the various TrkB mutant proteins to activate pathways leading to gene regulation, we tested each for its ability to induce expression of the Fos protein. Each cell line was stimulated with BDNF for 60 min and nuclei were harvested, lysed, fractionated by SDS ± PAGE and immunoblotted with an anti-c-fos speci®c antibody. As seen in Figure 5 , wild type TrkB and TrkB Y670F receptors induce robust levels of c-fos protein.
Coincident with their inability to activate ERK1 and ERK2, cells expressing K540A, YYY670/674/675FFF or YY674/675FF do not induce detectable c-fos protein levels in response to BDNF.
BDNF-inducible viability and proliferation of TrkB-3T3 cells
An interesting characteristic of the Trk RTKs is their ability to elicit mitogenic or proliferative responses depending on the cellular context in which they are expressed. Previous reports have shown that expression of TrkA, TrkB or TrkC in NIH3T3 ®broblasts induces a potent mitogenic response when stimulated with their respective ligands (Cordon-Cardo et al., 1991; Glass et al., 1991; Lambelle et al., 1991) . Indeed, TrkA was originally identi®ed as an oncogenic protein that led to the ligand-independent transformation of NIH3T3 cells (Martin-Zanca et al., 1989) .
To test the eects of the various mutations on TrkB-NIH3T3 cell proliferation, we ®rst made cells quiescent by serum starvation in de®ned media. Cells were then exposed to BDNF for 5 days, harvested and the number of cell divisions determined by counting cells with a hemacytometer. As positive and negative controls for each cell line tested, parallel dishes of cells were exposed to normal serum-containing As shown on Figure 6 , cells grown in de®ned media lacking added factors generally remained quiescent or were not viable at the end of the 5 day assay. All cell lines exposed to serum containing medium displayed similar growth rates, doubling an average of six times during the 5 day assay. Similarly, cells expressing wild type TrkB produced a potent mitogenic response following BDNF exposure, doubling ®ve times over the 5 day period. BDNF treatment of cells expressing the Y670F receptors exhibited a more modest level of proliferation, doubling an average of 2.5 ± 3 times during the assay. These data indicate that although TrkB Y670F can undergo BDNF-inducible autophosphorylation and stimulate ERK1/2 activation and cfos protein synthesis, its mitogenic signaling capabilities are somewhat impaired. This reduction in proliferation may be due to the inability of TrkB Y670F to phosphorylate PLCg, raising the possibility that the PLCg signaling pathway may be critical for TrkB mediated mitogenicity. BDNF treatment of the K540A, YY674/675FF, and YYY670/674/675FFF expressing cells induced no detectable increase in cell number. In general, most of these cells were nonviable by day three of the experiment. However, cells expressing TrkB YY674/675FF, even in the absence of BDNF, remained viable, but quiescent 5 ± 6 days postserum starvation. Since, TrkB YY674/675FF is capable of in vivo autophosphorylation (Figure 2a) , and possesses in vitro kinase activity (Figure 2b ), low levels of intracellular signaling may occur in these cells, possibly accounting for their extended survival period.
Discussion
This study was designed to investigate the role of speci®c tyrosine residues of the TrkB RTK in BDNFinduced signal transduction. More speci®cally, we have coupled site directed mutagenesis and cDNA transfection strategies in order to assess the biochemical and Figure 5 Eects of TrkB mutations on BDNF-induced c-fos protein synthesis. The various TrkB-3T3 cells were serum starved prior to the addition of BDNF for 1 h. Following cell lysis and isolation of nuclei, equivalent amounts of nuclear lysates (100 mg/ lane) were fractionated by SDS ± PAGE. Fos protein levels were detected by immunoblotting with the c-fos speci®c polyclonal antibody SC-4 (Santa Cruz Biotech). The 65 kDa band present in all lanes is a non-speci®c protein which cross-reacts with the c-fos antibody Figure 6 TrkB-3T3 cellular proliferation. The various TrkB-3T3 cell lines were seeded onto six well dishes pre-coated with ®bronectin and poly L-lysine, and serum starved in de®ned media for 24 h prior to the addition of BDNF. 5 days later, cells were harvested and the number of cell doublings was determined by counting with a hemacytometer. The experiment was performed three separate times. These data are from one representative experiment cell biological consequences of tyrosine mutations within the putative TrkB kinase activation loop.
Sequence alignments of the tyrosine kinase domains from various eukaryotic proteins suggest a number of distinct subdomains (designated I-XI). Within each subdomain, invariant amino acids are presumed to play critical structural/functional roles (for reviews, see Morgan and De Bondt, 1994; Hanks and Hunter, 1995) . Studies of invariant tyrosine 416 within subdomain VII of the pp60-src kinase (corresponding to Y674 in TrkB) identi®ed this residue as a major site of phosphorylation and crucial for ecient kinase activation (Cooper et al., 1986) . Mutagenesis studies in the human insulin receptor indicate that phosphorylation of three subdomain VII tyrosines (Y1158, Y1162, Y1163; corresponding to Y670, Y674, and Y675 in TrkB) is necessary for complete kinase activation, allowing the subsequent phosphorylation of other more distal tyrosines. The receptor phosphorylation events seem to be sequentially ordered and temporally regulated. Single substitutions of phenylalanine for tyrosine at the human insulin receptor tyrosines 1162 or 1163 results in a signi®cant reduction in receptor catalytic activity, with combined mutations at any of the three sites leading to increasingly diminished cytoplasmic signaling responses (Flores-Riveros et al., 1989; Wilden et al., 1990; Zhang et al., 1991; Murakami and Rosen, 1991) . More recently, Longati et al. (1994) and Mohammadi et al. (1996a) have reported that single or double tyrosine to phenylalanine substitutions at tyrosines corresponding to 674 and 675 in TrkB within the hepatocyte growth factor (HGF) and ®broblast growth factor (FGF) receptor subdomain VII, respectively, greatly impair ligandstimulated RTK activity, as well as the activation of subsequent signal transduction events.
Recent crystallographic structures for the unphosphorylated insulin and FGF receptor tyrosine kinase domains suggest critical roles for subdomain VII tyrosines (Hubbard et al., 1994; Mohammadi et al., 1996b) . The subdomain VII invariant tyrosines are proposed to lie within a structurally¯exible`kinase activation loop'. Phosphorylation of at least a subset of activation loop tyrosines (especially Y1162 in the human insulin receptor) is believed to facilitate the accessibility of ATP for the active site, and may also enhance kinase activity by allowing the active site greater access to the polypeptide substrate. Indeed, a crystal structure of the tyrosine phosphorylated insulin receptor kinase domain suggests that phosphorylation structurally stabilizes the activation loop in a conformatin that enhances active site accessibility to ATP (S. Hubbard, personal communication) . Consistent with the mutagenesis data, phenylalanine substitutions at subdomain VII/activation loop tyrosines are predicted to inhibit the ligand-induced conformational change, resulting in impaired kinase activation. Original work by White et al. (1988) also suggests that phosphorylation of the insulin receptor activation loop tyrosines occurs in a temporally ordered manner and is necessary for the phosphorylation of tyrosines outside the kinase domain. More recent analyses by Segal et al. (1996) using TrkA phospho-speci®c antibodies shows that activation loop tyrosine phosphorylation precedes and enhances the phosphorylation of the more distal tyrosines Y490 and Y785. The dephosphorylation of these residues also seems to be regulated, with pY674 and pY675 being rapidly dephosphorylated, and pY490 remaining phosphorylated for an extended time.
Because of the high degree of sequence similarity (50% identity) between the TrkA, TrkB, TrkC, and insulin receptor kinase domains, it was expected that Trk activation loop tyrosines would possess a similar regulatory role. Indeed, such a role was supported initially by studies conducted by Mitra (1991) . Using the oncogenic TrkA protein, single phenylalanine substitutions at tyrosines 503 or 504 (corresponding to TrkB Y674 and Y675) resulted in a dramatic decrease in both in vitro kinase activity and transformation potential. Stephens et al. (1994) showed that a proto-oncogene derived TrkA protein containing phenylalanine substitutions at both tyrosines 674 and 675 resulted in autophosphorylation de®cient receptors. However, Segal et al. (1996) showed that phosphorylation of TrkA Y490 occurs in receptors containing a YY674/675FF double substitution, indicating the presence of catalytic activity in these receptors. More recently, Cunningham et al. (1997) have shown that PC12 cells expressing TrkA YY674/ 675FF, while not able to extend neurites, are capable of signi®cant levels of NGF-inducible TrkA autophosphorylation. Similarly, Guiton et al. (1994) have shown that TrkB receptors containing phenylalanine substitutions at both Y674 and Y675, while not capable of stimulating BDNF-inducible transcription events, are still somewhat capable of BDNF-inducible receptor autophosphorylation. Interestingly, Guiton et al. (1994) , using phosphopeptide mapping strategies, detected a phosphopeptide with a mobility consistent with that of the predicted pY785 peptide in TrkB YY674/675FF receptors, but reported no phosphorylation of the TrkB Y484 site (corresponding to TrkA Y490).
Consistent with the work of Guiton et al. (1994); Segal et al. (1996) , and Cunningham et al. (1997) , we show that signi®cant levels of BDNF-inducible autophosphorylation occurs in receptors containing phenylalanine substitutions at both TrkB tyrosines 674 and 675 (Figure 2a) . We extend these ®ndings to show that TrkB YY674/675FF expressing cells are greatly impaired in their abilities to activate downstream signaling events. Although these receptors can autophosphorylate, they are incapable of inducing detectable phosphorylation of cytoplasmic proteins (Figure 3) . Furthermore, TrkB YY674/675FF is incapable of stimulating the phosphorylation and activation of ERK1 or ERK2 and is unable to induce the expression of c-fos protein (Figures 4 and 5) . Unlike NIH3T3 cells expressing wild type TrkB, TrkB YY674/675FF cells are impaired in their ability to proliferate in response to BDNF (Figure 6 ). Similarly, PC12 cells expressing TrkB YY674/675FF also are incapable of BDNF-inducible neurite outgrowth (McCarty and Feinstein, unpublished data) .
How might TrkB YY674/675FF be capable of autophosphorylation yet be defective in the activation of signaling responses? One possibility is that this mutant may be able to phosphorylate at appropriate tyrosines, but with reduced eciency. Perhaps the loss of signaling capability re¯ects the inability of the receptor to reach a requisite threshold level of phosphorylation of itself and cytosolic substrates. Alternatively, perhaps dimerization induced kinase activation proceeds, but the YY674/675FF mutation causes loss of the necessary temporal pattern of phosphorylation among the dierent tyrosines. Finally, it is possible that phosphorylation of tyrosines 674 and 675, although not essential for complete activation of the TrkB kinase domain and the subsequent phosphorylation of tyrosines 484 and 785, may be required for ecient association of the receptor with various signaling molecules (e.g., SHC and PLCg). Phosphorylation of Y674 and Y675 may contribute to establishing a proper structural conformation, allowing the TrkB intracellular region to interact productively with downstream signaling molecules. Therefore, while TrkB YY674/675FF is catalytically active, this mutant protein may be incapable of interacting with other necessary cytoplasmic factors because of an aberrant structural conformation. Indeed, data in Figure 3 demonstrate that TrkB YY674/675FF is incapable of inducing the tyrosine phosphorylation of various cellular proteins, including SHC and PLCg, consistent with the inability to associate with those substrates.
Site directed mutagenesis of tyrosine 670 also exhibits a slightly reduced, but still very signi®cant level of autophosphorylation. This result is consistent with that of Longati et al. (1994) , who detected no signi®cant decrease in receptor autophosphorylation after mutating the corresponding tyrosine (Y1230) within the HGF receptor. Similarly, mutation of the homologous tyrosine within the insulin receptor (Y1158) does not signi®cantly impair receptor autophosphorylation in response to insulin (Zhang et al., 1991) ; however, induction of DNA synthesis, glycogen synthesis, and glucose uptake are all compromised in cells expressing this receptor mutation (Wilden et al., 1990) . Interestingly, TrkB Y670F receptors remain capable of stimulating the phosphorylation of multiple cytoplasmic proteins, including SHC (Figure 3d ), activation of ERK1/2 (Figure 4) , and an increase in c-fos protein levels ( Figure 5 ). However, TrkB Y670F receptors are not capable of stimulating PLCg phosphorylation, indicating a functional impairment. A similar lack of PLCg phosphorylation in PC12 cells expressing TrkA Y670F was recently reported by Cunningham et al. (1997) . Further supporting this signaling de®ciency, NIH3T3 cells expressing TrkB Y670F are compromised in their ability to proliferate in response to BDNF. These cells repeatedly generate a mitogenic response that is 55 ± 65% of that observed with cells expressing wild type TrkB (Figure 6 ), con®rming that proper phosphorylation of Y670 is necessary for complete BDNF-inducible proliferation. Phosphorylation of this tyrosine might aect proliferation by imparting an important conformational change which in turn aects subsequent association with various signaling components, including PLCg. Alternatively, and recently proposed by Cunningham et al. (1997) , mutating Y670 may not allow the receptor to phosphorylate Y785, thus precluding association with PLCg. However, based on the phosphopeptide mapping data of Guiton et al. (1994) , this possibility seems unlikely. TrkB Y670F proteins showed a BDNFinducible phosphopeptide migration pattern similar to that of wild type TrkB, suggesting that these receptors indeed contain phosphorylated Y785. Consistent with this data, NIH3T3 cells expressing TrkB Y785F are completely impaired in their ability to survive and proliferate in response to BDNF, indicating that Y785 phosphorylation is required for a proper mitogenic response (McCarty and Feinstein, unpublished data) . If TrkB Y670F receptors were incapable of phosphorylating Y785, a complete loss of proliferative ability (rather than the observed 40 ± 50% decrease) would be expected. Another possibility to account for the observed decrease in TrkB Y670F survival is that pY670 serves as a docking site for a cytosolic protein involved in signaling. Consistent with this possibility, a comparison of the BDNF-inducible phosphoproteins reveals a protein of approximately 50 kDa that is phosphorylated in TrkB WT cells but not in TrkB Y670F cells (Figure 3a) .
The most extreme signaling impairment was observed in cells expressing the TrkB YYY670/674/ 675FFF triple mutant. Although TrkB YYY670/674/ 675FFF exhibited low levels of in vitro kinase activity (Figure 2b ), a complete lack of receptor autophosphorylation ( Figure 2a Finally, the neurotrophins are known to elicit numerous biological responses, ranging from neuroblast proliferation in the early stages of neuronal development to promoting and maintaining the dierentiated state in later stages of development and in maturity (Davies, 1994) . The expression of TrkB and BDNF also correlate well with higher levels of invasiveness in human neuroblastoma cells (Nakagawara et al., 1994; Matsumoto et al., 1995) . Consistent with these results, inappropriate expression of a mutated trk gene, which encodes a constitutively active kinase, was responsible for a human colon carcinoma (Martin-Zanca et al., 1986) , leading to the original identi®cation of the ®rst member of the Trk family, TrkA (Martin-Zanca et al., 1989) . This range of physiological responses to the same ligand-receptor pair highlights the importance of cellular context in determining the outcome of the signal transduction cascade. Thus, understanding the mechanism of Trk receptor action in dierent cellular contexts, both neuronal and non-neuronal, should lend insights into the varied eects of these versatile receptors.
Materials and methods
Antibodies and plasmids
Recombinant human BDNF and the pBJ5 plasmid (Elliot et al., 1990) were kind gifts from Andy Welcher, AMGEN (Thousand Oaks, CA), Phospho-speci®c ERK1/2 antibody was purchased from New England Biolabs (Beverly, MA). Anti-ERK1/2 (SC-4) and anti-c-fos antibody (SC-52) were both purchased from Santa Cruz Labs (Santa Cruz, CA). Anti-SHC was purchased from Transduction Labs (Lexington, KY) and anti-PLCg was purchased from UBI (Lake Placid, NY). Anti-phosphotyrosine PY20:HRP antibody was purchased from Transduction Laboratories (Lexington, KY). Goat-anti rabbit IgG:HRP secondary antibody was purchased from Biorad (Hercules, CA). PanTrk polyclonal antisera was generated using a peptide antigen corresponding to the last 15 amino acids (775 ± 790); QNLAKASPVYLDILG) of rat TrkB. Anti-trkB348 ± 363 polyclonal antisera was generated and anity puri®ed using an antigen peptide corresponding to amino acids 348 ± 363 of rat TrkB (MGRPGVDYETNPNYPE). The 4.7 kbp rat TrkB cDNA was a kind gift from Tony Hunter (The Salk Institute) and has been described elsewhere (Middlemas et al., 1991) .
Mutagenesis, cell culture, and TrkB expression
Site-directed mutagenesis of the rat TrkB cDNA was performed using the Transformer Kit from Clontech (Palo Alto, CA). The sequences of the oligonucleotides used for mutagenesis are as follows: K540A, 5'-GTGGCCGTGGCGACGCTGAAG-3'; Y670F, 5'-CG-GGATGTATTCAGCACCGAC-3'; YY674/675FF, 5'-TA-CAGCACCGACTTCTTCCGGGTTGGTGGC -3'; YYY-670/74/75FFF, 5'-ATGTCCCGGGATGTATTCAGCAC-CGACTTCTTCCGGGTTGGTGGCCAC-3'. All mutated cDNAs were sequenced to con®rm the presence of the desired point mutation(s).
NIH3T3 cells, which do not normally express TrkB, were co-transfected with 1 mg pSV2neo and 20 mg pBJ5 into which the rat TrkB cDNA (wild type or receptors containing the various point mutations) had been subcloned. Transfections were performed using the calcium phosphate procedure (Wigler et al., 1979) . Stable transfectants were selected in 400 mg/ml G418 (Sigma) and subsequently maintained in 150 mg/ml G418. Resistant clones were isolated and tested for TrkB expression by immunoblotting 50 mg of NP-40 soluble lysates (NP-40 lysis buer; 20 mM Tris, pH=7.4, 150 mM NaCl, 5 mM EDTA, 10% glycerol, 1% Nonidet P-40, 1 mM sodium orthovanadate, 50 mM sodium pyrophosphate, 50 mM sodium¯uoride, 1 mM PMSF, 2.5 mg/ml pepstatin and 2.5 mg/ml leupeptin) with the anti-trkB348 ± 363 polyclonal antibody. Unless otherwise noted, all cells were grown in Dulbecco's modi®ed Eagle's medium (Gibco BRL) supplemented with 5% horse serum and 5% calf serum (Gemini; Calabasas, CA).
Immunoprecipitation and immunoblotting
To assess the BDNF-inducible tyrosine phosphorylation of wild type and mutant TrkB receptors, cells were serum starved overnight in DMEM supplemented with 0.1% calf serum. The next day, approximately 1610 7 cells (3.3610 6 cells/ml) in suspension were treated with 50 ng/ml BDNF at 378C for various times. Cells were lysed in NP-40 lysis buer, and the soluble fraction was clari®ed by centrifugation for 10 min in a Beckman microfuge at 14 000 g at 48C.
Following quantitation of protein concentrations using the Amido-Schwarz assay (Schaner and Weissman, 1973) , TrkB was immunoprecipitated by mixing 500 mg of lysate (1 mg/ml) with 5 mg pan-Trk polyclonal antisera for 2 ± 4 h at 48C. The lysates were then incubated at 48C for 1 h with 25 ml (1 : 3 slurry) of Protein A-Sepharose (Sigma). The immunoprecipitates were washed three times with NP-40 lysis buer, boiled in 2X sample buer and electrophoresed on an 8% SDS-polyacrylamide gel. Following electrotransfer to nitrocellulose (Schleicher and Scheull Inc.) and blocking in TBST (20 mM Tris, pH=7.4, 137 mM NaCl, 0.2% Tween-20) containing 3% bovine serum albumin (BSA), membranes were probed overnight at 48C with PY20:HRP (1 : 3000) in TBST-BSA.
To assess the phosphorylation states of SHC and PLCg, similar amounts of NP-40 soluble lysate were used for immunoprecipitations. SHC was immunoprecipitated using 2 mg anity puri®ed antibody, and PLCg was immunoprecipitated using 0.3 ml of total antisera. Immunoblots using antiphosphotyrosine were performed as described above. To test the association between TrkB with SHC and PLCg, immunoprecipitations of SHC and PLCg were performed as described above and TrkB was detected by probing immunoblots with anti-TrkB(348 ± 363) antisera. All detection of antibody binding was performed using the Supersignal chemiluminescence kit (Pierce).
BDNF inducible cellular tyrosine phosphorylation and ERK1/2 activation were determined by serum starving 2.5610 6 cells for 48 h followed by treatment (in suspension) for 0, 5, or 15 min with 50 ng/ml BDNF. Cells were lysed in NP-40 lysis buer and for each timepoint 25 mg soluble lysate was electrophoresed (8% SDS ± PAGE), blotted, and probed with PY20:HRP or phospho-speci®c ERK1/2 antibodies, respectively (both diluted 1 : 3000 in TBST, 3% BSA).
Induction of c-fos protein was determined in monolayer cultures by serum starving 1610 6 cells for 24 h followed by a 1 h treatment with 50 ng/ml BDNF. Cells were lysed in 20 mM Tris, pH=7.4, 150 mM NaCl, 0.1% Triton X-100, 5 mM EDTA, 1 mM PMSF, 2.5 mg/ml pepstatin, 2.5 mg/ml leupeptin, and nuclei were isolated by a 48C centrifugation for 5 min at 1146 g (2500 r.p.m.) in a Sorvall GLC-2B tabletop centrifuge. Following solubilizing in sample buer, crude nuclear proteins were resolved on a 10% SDSpolyacrylamide gel, blotted and probed with anti-c-fos speci®c antisera followed by a goat anti-rabbit IgG:HRP 28 antibody (both diluted 1 : 3000 in TBST, 5% Blotto).
In vitro kinase assay
Semi-con¯uent 10 cm dishes of NIH3T3 cells expressing wild type TrkB or the various TrkB mutant proteins were serum starved for 18 h using DMEM containing 0.1% BSA. The cells were harvested and lysed in 1 ml of NP-40 lysis buer. TrkB was immunoprecipitated from the soluble lysate fractions (2 mg/ml) with 25 mg pan-Trk (IgG fraction) for 2 h at 48C, followed by a 1 h incubation with 25 ml Protein A-Sepharose (1 : 3 slurry). The immunoprecipitates were washed three times with lysis buer and incubated for 30 min at room temperature in 20 ml kinase buer (20 mM Tris, pH=7.4, 10 mM MnCl 2 , 5 mg MBP, 50 mCi [ 32 P]g-ATP). The kinase reactions were terminated with 26SDS ± PAGE sample buer and the proteins were resolved on a 15% SDS reducing gel, followed by autoradiography.
Growth assays
To measure growth factor induced viability and proliferation, cells were seeded in de®ned media (Zhan and Goldfarb, 1986 ) onto six-well dishes (1610 5 cells/well) precoated with 50 mg/ml poly-L lysine and 2.5 mg/ml ®bronectin (Sigma). The de®ned media consisted of a 3 : 1 mixture of DMEM and Ham's F12 medium supplemented with 15 mM HEPES, pH=7.4, 4 mM manganese chloride, 3 mM histidine, 10 mM ethanolamine, 16ITSE+1 (10 mg/l insulin, 5.5 mg/l transferrin, 5 mg/l selenium, 0.5 mg/l BSA, 4.7 mg/l linoleic acid; Sigma, Inc.), 2 mM hydrocortisone and 150 mg/ml G418. The following day (de®ned as day 0), fresh, de®ned media containing 50 ng/ml BDNF was added to the various cell lines. As a negative control, de®ned media containing no BDNF was added. To serve as a positive control, DMEM media containing 5% horse serum and 5% supplemented calf serum was used. Media was replaced every 24 h, and on day 5 cell lines were assessed for proliferation by counting with a hemacytometer. The ability to proliferate in response to the various media conditions was determined by counting triplicate samples in three independent experiments.
